ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients With Influenza A Infection
EudraCT number 2017-002156-84
Protocol number 63623872FLZ3001
Sponsor Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
Indications Infection (including sepsis, antibiotics)
Diagnosis Influenza A Infection
Population in clinical trial Adolescents (12-17 years)
Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2018
Date of approval by Institute (SÚKL) 16.7.2018
Date of approval by EC 4.4.2018
Date of initiation CT in ČR 19.12.2019
Date of ending CT in ČR 11.9.2020
Sites Nemocnice Na Bulovce,Klinika infekčních, parazitárních a tropických nemocí,Budínova 67/2,Praha 8,180 81
Fakultní nemocnice Brno,Klinika infekčních chorob,Jihlavská 20 ,Brno ,625 00
Nemocnice Kyjov,Infekční oddělení,Strážovská 1247/22,Kyjov ,697 01
Fakultní nemocnice Ostrava,Klinika infekčního lékařství FNO a LF OU,17. listopadu 1790/5,Ostrava - Poruba ,708 52

‹‹ Back to list